Načítá se...
Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
Vilazodone is a potent selective serotonin reuptake inhibitor and serotonin 1A receptor partial agonist approved for the treatment of major depressive disorder in adults. To assess the efficacy of vilazodone across a range of symptoms and severities of depression, data from two phase III, 8-week, ra...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams And Wilkins
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3901802/ https://ncbi.nlm.nih.gov/pubmed/24247740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|